Privacy Act, Exempt Record System; Withdrawal, 2892 [2013-00723]
Download as PDF
<![CDATA[
2892
Federal Register / Vol. 78, No. 10 / Tuesday, January 15, 2013 / Rules and Regulations
indicate that venue for challenges to be
in the D.C. Circuit. Accordingly, the
EPA is determining that this is a rule of
nationwide scope or effect. In addition,
pursuant to CAA section 307(d)(1)(V),
the EPA is determining that this
rulemaking action will be subject to the
requirements of section 307(d). Under
section 307(b)(1) of the CAA, petitions
for judicial review of this action must be
filed in the United States Court of
Appeals for the District of Columbia
Circuit Court within 60 days from the
date final action is published in the
Federal Register. Filing a petition for
review by the Administrator of this final
action does not affect the finality of the
action for the purposes of judicial
review nor does it extend the time
within which a petition for judicial
review must be filed, and shall not
postpone the effectiveness of such rule
or action. Thus, any petitions for review
of this action must be filed in the Court
of Appeals for the District of Columbia
Circuit within 60 days from the date
final action is published in the Federal
Register.
List of Subjects in 40 CFR Part 52
Approval and promulgation of
implementation plans, Environmental
protection, Administrative practice and
procedures, Air pollution control,
Incorporation by reference,
Intergovernmental relations and
Reporting and recordkeeping
requirements.
Dated: January 4, 2013.
Gina McCarthy,
Assistant Administrator, Office of Air and
Radiation.
provisions of the Privacy Act of 1974 in
order to protect the integrity of NIH
research misconduct proceedings and to
protect the identity of confidential
sources in such proceedings. The
comment period for this direct final rule
closed November 13, 2012. HHS is
withdrawing the direct final rule
because the agency has received
significant adverse comment.
DATES: The direct final rule published at
77 FR 51933, August 28, 2012, is
withdrawn effective January 10, 2013.
FOR FURTHER INFORMATION CONTACT:
Karen Pla, the NIH Privacy Act Officer,
by email at KarenPla@nih.gov or by
telephone on 301–402–6201; and/or
Jerry Moore, the NIH Regulations
Officer, by email at jm40z@nih.gov or by
telephone on 301–496–4607.
SUPPLEMENTARY INFORMATION: HHS and
NIH published in the Federal Register
of August 28, 2012 (77 FR 51933), a
direct final rule to exempt a new system
of records, 09–25–0223, ‘‘NIH Records
Related to Research Misconduct
Proceedings, HHS/NIH,’’ from certain
provisions of the Privacy Act of 1974 in
order to protect the integrity of NIH
research misconduct proceedings and to
protect the identity of confidential
sources in such proceedings. HHS is
withdrawing the direct final rule
because the agency has received
significant adverse comment.
Authority: Therefore, pursuant to 5 U.S.C.
301 and 552a, the direct final rule published
on August 28, 2012 (77 FR 51933) is
withdrawn.
Dated: January 10, 2013.
Kathleen Sebelius,
Secretary, Department of Health and Human
Services.
[FR Doc. 2013–00566 Filed 1–14–13; 8:45 am]
BILLING CODE 6560–50–P
[FR Doc. 2013–00726 Filed 1–10–13; 4:15 pm]
and Drug Administration (FDA) are
withdrawing the direct final rule that
August 28, 2012. HHS/FDA published
the direct final rule to exempt scientific
research misconduct proceedings
records from certain requirements of the
Privacy Act of 1974 in order to protect
records compiled in the course of
misconduct inquiries and
investigations, and to safeguard the
identity of confidential sources. The
comment period closed on November
13, 2012. HHS/FDA is withdrawing the
direct final rule because the Agency
received significant adverse comment.
Effective Date: The direct final
rule published at 77 FR 51910, August
28, 2012, is withdrawn effective January
10, 2013.
DATES:
FOR FURTHER INFORMATION CONTACT:
Frederick Sadler, Division of Freedom
of Information, Food and Drug
Administration, 12420 Parklawn Dr.,
Rockville, MD 20857, 301–796–8975,
Frederick.Sadler@fda.hhs.gov.
HHS and
FDA are withdrawing the direct final
rule that published in the Federal
Register of Tuesday, August 28, 2012
(77 FR 51910). HHS/FDA published the
direct final rule to exempt scientific
research misconduct proceedings
records from certain requirements of the
Privacy Act of 1974 in order to protect
records compiled in the course of
misconduct inquiries and
investigations, and to safeguard the
identity of confidential sources. The
comment period closed on November
13, 2012. HHS/FDA is withdrawing the
direct final rule because the Agency
received significant adverse comment.
SUPPLEMENTARY INFORMATION:
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Food and Drug Administration
45 CFR Part 5b
[Docket Number NIH–2011–0001]
21 CFR Part 21
Privacy Act, Exempt Record System;
Withdrawal
[Docket No. FDA–2011–N–0252]
Department of Health and
Human Services, National Institutes of
Health.
ACTION: Direct final rule; withdrawal.
wreier-aviles on DSK5TPTVN1PROD with
AGENCY:
The Department of Health and
Human Services (HHS) and the National
Institutes of Health (NIH) published in
the Federal Register of August 28, 2012,
a direct final rule to exempt a new
system of records from certain
SUMMARY:
VerDate Mar<15>2010
14:53 Jan 14, 2013
Jkt 229001
Authority: Therefore, under 5 U.S.C. 552a,
the direct final rule published on Tuesday,
August 28, 2012, 77 FR 51910, is withdrawn.
Dated: January 10, 2013.
Approved:
Kathleen Sebelius
Secretary, Department of Health and Human
Services.
[FR Doc. 2013–00723 Filed 1–10–13; 4:15 pm]
Office of the Secretary
BILLING CODE 4160–01–P
45 CFR Part 5b
Privacy Act, Exempt Record System;
Withdrawal
Office of the Secretary, Food
and Drug Administration, HHS.
ACTION: Direct final rule; withdrawal.
AGENCY:
The Department of Health and
Human Services (HHS) and the Food
SUMMARY:
PO 00000
Frm 00014
Fmt 4700
Sfmt 9990
E:\FR\FM\15JAR1.SGM
15JAR1
]]>Agencies
[Federal Register Volume 78, Number 10 (Tuesday, January 15, 2013)]
[Rules and Regulations]
[Page 2892]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00723]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 21
[Docket No. FDA-2011-N-0252]
Office of the Secretary
45 CFR Part 5b
Privacy Act, Exempt Record System; Withdrawal
AGENCY: Office of the Secretary, Food and Drug Administration, HHS.
ACTION: Direct final rule; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) and the Food
and Drug Administration (FDA) are withdrawing the direct final rule
that August 28, 2012. HHS/FDA published the direct final rule to exempt
scientific research misconduct proceedings records from certain
requirements of the Privacy Act of 1974 in order to protect records
compiled in the course of misconduct inquiries and investigations, and
to safeguard the identity of confidential sources. The comment period
closed on November 13, 2012. HHS/FDA is withdrawing the direct final
rule because the Agency received significant adverse comment.
DATES: Effective Date: The direct final rule published at 77 FR 51910,
August 28, 2012, is withdrawn effective January 10, 2013.
FOR FURTHER INFORMATION CONTACT: Frederick Sadler, Division of Freedom
of Information, Food and Drug Administration, 12420 Parklawn Dr.,
Rockville, MD 20857, 301-796-8975, Frederick.Sadler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: HHS and FDA are withdrawing the direct final
rule that published in the Federal Register of Tuesday, August 28, 2012
(77 FR 51910). HHS/FDA published the direct final rule to exempt
scientific research misconduct proceedings records from certain
requirements of the Privacy Act of 1974 in order to protect records
compiled in the course of misconduct inquiries and investigations, and
to safeguard the identity of confidential sources. The comment period
closed on November 13, 2012. HHS/FDA is withdrawing the direct final
rule because the Agency received significant adverse comment.
Authority: Therefore, under 5 U.S.C. 552a, the direct final rule
published on Tuesday, August 28, 2012, 77 FR 51910, is withdrawn.
Dated: January 10, 2013.
Approved:
Kathleen Sebelius
Secretary, Department of Health and Human Services.
[FR Doc. 2013-00723 Filed 1-10-13; 4:15 pm]
BILLING CODE 4160-01-P
